Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 7Neurofibroma, Plexiform 4Neoplasms 2Melanoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Pancreatic Neoplasms 1Pain 1Neurofibrosarcoma 1Kidney Neoplasms 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1Advanced Non Small Cell Lung Cancer 1Adenocarcinoma 1

Interventions

Saline Solution 2Oxycodone 2Methods 2Acetaminophen 2siltuximab 1pegfilgrastim 1oxycodone-acetaminophen 1erenumab 1Xylitol 1Therapeutics 1Telemedicine 1Surveys and Questionnaires 1STAMP-I protocol 1Remifentanil 1Range of Motion, Articular 1Physical Therapy Modalities 1Myofascial Release Therapy 1Music Therapy 1Morphine 1Methadone 1Massage 1Kyphoplasty 1Ketorolac Tromethamine 1Ketorolac 1High-Energy Shock Waves 1Electroacupuncture 1Early Intervention, Educational 1Chewing Gum 1Case Management 1Betaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pain × AZD 6244 × 90 days × Clear all
NCT01362803 2026-06-01

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡